Avricore Total Liab vs Net Debt Analysis

AVCR Stock

CAD 0.06 0.01 9.09%

Avricore Health financial indicator trend analysis is way more than just evaluating Avricore Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avricore Health is a good investment. Please check the relationship between Avricore Health Total Liab and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avricore Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Total Liab vs Net Debt

Total Liab vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avricore Health Total Liab account and Net Debt. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Avricore Health's Total Liab and Net Debt is 0.51. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Net Debt in the same time period over historical financial statements of Avricore Health, assuming nothing else is changed. The correlation between historical values of Avricore Health's Total Liab and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Avricore Health are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Total Liab i.e., Avricore Health's Total Liab and Net Debt go up and down completely randomly.

Correlation Coefficient

0.51

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most indicators from Avricore Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avricore Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avricore Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Enterprise Value is likely to climb to about 15.8 M in 2025, whereas Selling General Administrative is likely to drop slightly above 1.2 M in 2025.

	2021	2024	2025 (projected)
Depreciation And Amortization	18.0K	210.5K	221.0K
Income Tax Expense	38.4K	44.2K	50.5K

Depreciation And Amortization Income Tax Expense

Avricore Health fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Total Liab	Total Current Assets	Common Stock	Property Plant And Equipment Net	Accounts Payable	Non Currrent Assets Other	Other Stockholder Equity	Other Current Liab	Inventory	Other Current Assets	Intangible Assets	Short Term Investments	Net Tangible Assets	Property Plant Equipment	Net Invested Capital	Net Working Capital
Total Assets		-0.35	0.97	-0.6	-0.35	0.64	0.48	0.58	0.55	0.4	-0.35	0.81	0.39	0.47	0.02	-0.29	0.63	-0.23	0.32	0.02	0.35	-0.34	0.22	0.19	0.38	0.21
Total Current Liabilities	-0.35		-0.56	0.51	-0.28	-0.43	0.05	-0.37	-0.01	0.13	1.0	-0.41	0.31	0.09	0.42	-0.09	-0.24	0.57	-0.35	-0.22	-0.31	-0.39	-0.39	0.3	-0.38	-0.53
Total Stockholder Equity	0.97	-0.56		-0.66	-0.24	0.68	0.4	0.61	0.48	0.31	-0.57	0.82	0.27	0.37	-0.1	-0.22	0.62	-0.34	0.38	0.08	0.4	-0.2	0.3	0.09	0.44	0.33
Net Debt	-0.6	0.51	-0.66		0.02	-0.81	0.01	-0.95	0.01	-0.08	0.51	-0.69	-0.12	-0.03	0.17	0.07	-0.37	0.21	-0.08	-0.3	-0.29	0.07	-0.43	0.02	-0.43	-0.55
Retained Earnings	-0.35	-0.28	-0.24	0.02		0.02	-0.5	-0.14	-0.49	-0.84	-0.28	-0.06	-0.92	-0.53	-0.47	0.46	0.22	0.3	0.39	0.26	0.52	0.55	0.62	-0.71	0.49	0.5
Cash	0.64	-0.43	0.68	-0.81	0.02		-0.23	0.84	-0.16	-0.03	-0.43	0.89	0.03	-0.15	-0.35	0.03	0.5	-0.16	0.38	0.19	0.43	-0.12	0.37	-0.09	0.34	0.48
Non Current Assets Total	0.48	0.05	0.4	0.01	-0.5	-0.23		-0.02	0.63	0.73	0.05	-0.12	0.53	0.93	0.55	-0.58	-0.02	-0.18	-0.37	-0.13	-0.35	-0.23	-0.01	0.47	0.1	-0.27
Cash And Short Term Investments	0.58	-0.37	0.61	-0.95	-0.14	0.84	-0.02		-0.05	0.17	-0.37	0.67	0.21	0.04	-0.2	-0.1	0.29	-0.29	0.0	0.3	0.19	-0.12	0.28	0.11	0.31	0.39
Net Receivables	0.55	-0.01	0.48	0.01	-0.49	-0.16	0.63	-0.05		0.51	-0.01	0.19	0.45	0.59	0.21	-0.42	0.28	-0.1	0.08	-0.28	0.0	-0.26	-0.1	0.26	0.14	-0.07
Common Stock Shares Outstanding	0.4	0.13	0.31	-0.08	-0.84	-0.03	0.73	0.17	0.51		0.13	-0.04	0.79	0.83	0.51	-0.77	-0.33	-0.38	-0.5	-0.42	-0.7	-0.22	-0.31	0.71	-0.26	-0.41
Total Liab	-0.35	1.0	-0.57	0.51	-0.28	-0.43	0.05	-0.37	-0.01	0.13		-0.42	0.31	0.1	0.43	-0.09	-0.24	0.57	-0.35	-0.21	-0.31	-0.39	-0.39	0.29	-0.38	-0.53
Total Current Assets	0.81	-0.41	0.82	-0.69	-0.06	0.89	-0.12	0.67	0.19	-0.04	-0.42		0.07	-0.09	-0.34	0.06	0.73	-0.11	0.62	0.1	0.63	-0.24	0.27	-0.12	0.36	0.43
Common Stock	0.39	0.31	0.27	-0.12	-0.92	0.03	0.53	0.21	0.45	0.79	0.31	0.07		0.56	0.49	-0.5	-0.12	-0.18	-0.35	-0.17	-0.47	-0.66	-0.41	0.69	-0.27	-0.36
Property Plant And Equipment Net	0.47	0.09	0.37	-0.03	-0.53	-0.15	0.93	0.04	0.59	0.83	0.1	-0.09	0.56		0.62	-0.82	-0.13	-0.23	-0.35	-0.34	-0.49	-0.18	0.02	0.47	0.04	-0.34
Accounts Payable	0.02	0.42	-0.1	0.17	-0.47	-0.35	0.55	-0.2	0.21	0.51	0.43	-0.34	0.49	0.62		-0.47	-0.29	0.03	-0.43	-0.15	-0.48	-0.41	-0.31	0.39	-0.45	-0.61
Non Currrent Assets Other	-0.29	-0.09	-0.22	0.07	0.46	0.03	-0.58	-0.1	-0.42	-0.77	-0.09	0.06	-0.5	-0.82	-0.47		0.28	0.28	0.25	0.5	0.6	0.07	-0.11	-0.37	0.02	0.3
Other Stockholder Equity	0.63	-0.24	0.62	-0.37	0.22	0.5	-0.02	0.29	0.28	-0.33	-0.24	0.73	-0.12	-0.13	-0.29	0.28		0.27	0.77	0.33	0.85	-0.32	0.44	-0.25	0.62	0.53
Other Current Liab	-0.23	0.57	-0.34	0.21	0.3	-0.16	-0.18	-0.29	-0.1	-0.38	0.57	-0.11	-0.18	-0.23	0.03	0.28	0.27		0.11	-0.19	0.28	-0.15	0.27	-0.29	0.28	0.27
Inventory	0.32	-0.35	0.38	-0.08	0.39	0.38	-0.37	0.0	0.08	-0.5	-0.35	0.62	-0.35	-0.35	-0.43	0.25	0.77	0.11		0.06	0.78	-0.1	0.34	-0.54	0.4	0.39
Other Current Assets	0.02	-0.22	0.08	-0.3	0.26	0.19	-0.13	0.3	-0.28	-0.42	-0.21	0.1	-0.17	-0.34	-0.15	0.5	0.33	-0.19	0.06		0.39	-0.23	0.1	-0.03	0.15	0.19
Intangible Assets	0.35	-0.31	0.4	-0.29	0.52	0.43	-0.35	0.19	0.0	-0.7	-0.31	0.63	-0.47	-0.49	-0.48	0.6	0.85	0.28	0.78	0.39		-0.09	0.38	-0.56	0.51	0.52
Short Term Investments	-0.34	-0.39	-0.2	0.07	0.55	-0.12	-0.23	-0.12	-0.26	-0.22	-0.39	-0.24	-0.66	-0.18	-0.41	0.07	-0.32	-0.15	-0.1	-0.23	-0.09		0.25	-0.16	0.18	0.25
Net Tangible Assets	0.22	-0.39	0.3	-0.43	0.62	0.37	-0.01	0.28	-0.1	-0.31	-0.39	0.27	-0.41	0.02	-0.31	-0.11	0.44	0.27	0.34	0.1	0.38	0.25		-0.46	0.88	0.76
Property Plant Equipment	0.19	0.3	0.09	0.02	-0.71	-0.09	0.47	0.11	0.26	0.71	0.29	-0.12	0.69	0.47	0.39	-0.37	-0.25	-0.29	-0.54	-0.03	-0.56	-0.16	-0.46		-0.3	-0.41
Net Invested Capital	0.38	-0.38	0.44	-0.43	0.49	0.34	0.1	0.31	0.14	-0.26	-0.38	0.36	-0.27	0.04	-0.45	0.02	0.62	0.28	0.4	0.15	0.51	0.18	0.88	-0.3		0.82
Net Working Capital	0.21	-0.53	0.33	-0.55	0.5	0.48	-0.27	0.39	-0.07	-0.41	-0.53	0.43	-0.36	-0.34	-0.61	0.3	0.53	0.27	0.39	0.19	0.52	0.25	0.76	-0.41	0.82

Click cells to compare fundamentals

Avricore Health Account Relationship Matchups

Avricore Health fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	440.1K	2.3M	2.6M	2.5M	2.9M	3.1M
Total Current Liabilities	1.2M	84.5K	604.9K	529.2K	608.6K	409.8K
Total Stockholder Equity	(714.0K)	2.2M	2.0M	2.0M	2.3M	2.4M
Net Debt	7.6K	698.8K	(2.0M)	(580.5K)	(522.5K)	(548.6K)
Retained Earnings	(28.5M)	(30.2M)	(31.0M)	(31.7M)	(28.6M)	(27.1M)
Cash	302.7K	2.0M	620.5K	276.6K	318.1K	623.9K
Cash And Short Term Investments	13.8K	302.7K	2.0M	630.5K	725.1K	639.8K
Net Receivables	11.9K	91.5K	770.4K	421.0K	484.1K	508.4K
Common Stock Shares Outstanding	60.4M	92.6M	97.9M	99.6M	114.6M	120.3M
Liabilities And Stockholders Equity	208.4K	440.1K	2.3M	2.6M	3.0M	3.1M
Total Liab	1.2M	84.5K	604.9K	529.2K	608.6K	422.0K
Total Current Assets	440.1K	2.2M	1.4M	773.6K	889.6K	1.1M
Common Stock	21.4M	22.3M	26.6M	27.1M	31.1M	20.6M
Accounts Payable	126.6K	44.5K	261.5K	428.7K	493.0K	517.6K
Other Stockholder Equity	211.2K	110K	10K	5.8M	6.7M	7.2M
Accumulated Other Comprehensive Income	5.4M	5.5M	5.8M	5.9M	6.8M	7.2M
Other Current Liab	27K	26K	40K	51.4K	46.3K	43.9K
Inventory	102.5K	0.0	1.0	20.7K	23.8K	22.6K
Other Current Assets	179.1K	125.4K	54.5K	30.2K	34.8K	33.0K
Net Tangible Assets	460.2K	(465.5K)	(714.0K)	2.2M	1.9M	2.0M
Net Invested Capital	287.5K	2.2M	2.0M	2.0M	2.4M	1.5M
Net Working Capital	(714.0K)	2.1M	826.2K	244.3K	281.0K	266.9K
Capital Stock	22.3M	26.6M	27.1M	27.2M	31.3M	26.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Avricore Stock Analysis

When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC